NPPB and cardiotoxicity: In addition, the increase in NT-proBNP concentrations was more pronounced during the follow-up periods in women who developed cardiotoxicity than in women without cardiotoxicity (177.47 ± 53.72 ng/L vs. 129.87 ± 54.76 ng/L, p = 0.003).